Abstract

 
 

References (29)



 
 

Footnotes (15)



 


 



The Novelty Paradox & Bias for Normal Science: Evidence from Randomized Medical Grant Proposal Evaluations


Kevin J. Boudreau


London Business School; Harvard University - Institute for Quantitative Social Science

Eva Guinan


Harvard Medical School; Dana-Farber Cancer Institute

Karim Lakhani


Harvard Business School - Technology and Operations Management Group; Harvard University - Berkman Center for Internet & Society; Harvard Institute for Quantitative Social Science

Christoph Riedl


Harvard University - Institute for Quantitative Social Science

December 4, 2012

Harvard Business School Technology & Operations Mgt. Unit Working Paper No. 13-053

Abstract:     
Central to any innovation process is the evaluation of proposed projects and allocation of resources. We investigate whether novel research projects, those deviating from existing research paradigms, are treated with a negative bias in expert evaluations. We analyze the results of a peer review process for medical research grant proposals at a leading medical research university, in which we recruited 142 expert university faculty members to evaluate 150 submissions, resulting in 2,130 randomly-assigned proposal-evaluator pair observations. Our results confirm a systematic penalty for novel proposals; a standard deviation increase in novelty drops the expected rank of a proposal by 4.5 percentile points. This discounting is robust to various controls for unobserved proposal quality and alternative explanations. Additional tests suggest information effects rather than strategic effects account for the novelty penalty. Only a minority of the novelty penalty could be related to perceptions of lesser feasibility of novel proposals.

Number of Pages in PDF File: 39

Keywords: Project evaluation and resource allocation, expert review, open science, scientific paradigms, field experiment

working papers series


Download This Paper

Date posted: December 5, 2012  

Suggested Citation

Boudreau, Kevin J., Guinan, Eva, Lakhani, Karim R. and Riedl, Christoph, The Novelty Paradox & Bias for Normal Science: Evidence from Randomized Medical Grant Proposal Evaluations (December 4, 2012). Harvard Business School Technology & Operations Mgt. Unit Working Paper No. 13-053. Available at SSRN: http://ssrn.com/abstract=2184791 or http://dx.doi.org/10.2139/ssrn.2184791

Contact Information

Kevin J. Boudreau
London Business School ( email )
Sussex Place
Regent's Park
London, London NW1 4SA
United Kingdom
Harvard University - Institute for Quantitative Social Science ( email )
1737 Cambridge St.
Cambridge, MA 02138
United States
Eva Guinan
Harvard Medical School ( email )
250 Longwood Avenue
Boston, MA 02115
United States
Dana-Farber Cancer Institute ( email )
450 Brookline Avenue
Boston, MA 02115
United States
Karim R. Lakhani (Contact Author)
Harvard Business School - Technology and Operations Management Group ( email )
Boston, MA 02163
United States
617-495-6741 (Phone)
Harvard University - Berkman Center for Internet & Society
Harvard Law School, Baker House
1587 Massachusetts Avenue
Cambridge, MA 02138
United States
Harvard Institute for Quantitative Social Science
1737 Cambridge St.
Cambridge, MA 02138
United States
Christoph Riedl
Harvard University - Institute for Quantitative Social Science ( email )
1737 Cambridge St.
Cambridge, MA 02138
United States
HOME PAGE: http://christophriedl.net
Feedback to SSRN (Beta)


Paper statistics
Abstract Views: 2,457
Downloads: 420
Download Rank: 32,404
References:  29
Footnotes:  15

© 2013 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright
This page was processed by apollo7 in 0.735 seconds